BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16247037)

  • 1. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 2. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
    Crocker A; EspaƱa RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
    Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
    Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
    Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
    Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
    Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
    Sakurai T
    Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.
    Honda M; Arai T; Fukazawa M; Honda Y; Tsuchiya K; Salehi A; Akiyama H; Mignot E
    Neurology; 2009 Aug; 73(7):511-7. PubMed ID: 19687452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
    Dauvilliers Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.
    Sakurai T
    Nat Rev Neurosci; 2007 Mar; 8(3):171-81. PubMed ID: 17299454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor regarding our previous publication: "Secondary narcolepsy in children with brain tumors," SLEEP 2002; 25:435-439.
    Marcus CL; Mignot E
    Sleep; 2003 Mar; 26(2):228. PubMed ID: 12683485
    [No Abstract]   [Full Text] [Related]  

  • 13. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.
    Mignot E; Taheri S; Nishino S
    Nat Neurosci; 2002 Nov; 5 Suppl():1071-5. PubMed ID: 12403989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level.
    Dauvilliers Y; Abril B; Charif M; Quittet P; Bauchet L; Carlander B; Touchon J
    Neurology; 2007 Sep; 69(12):1300-1. PubMed ID: 17875919
    [No Abstract]   [Full Text] [Related]  

  • 15. Narcolepsy: a neurodegenerative disease of the hypocretin system?
    van den Pol AN
    Neuron; 2000 Sep; 27(3):415-8. PubMed ID: 11055422
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.
    Lodi R; Tonon C; Vignatelli L; Iotti S; Montagna P; Barbiroli B; Plazzi G
    Neurology; 2004 Oct; 63(8):1513-5. PubMed ID: 15505179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology.
    Sakurai T
    Regul Pept; 2005 Mar; 126(1-2):3-10. PubMed ID: 15620407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of hypocretin/orexin: accomplishments in sleep medicine.
    Thannickal TC
    Sleep Med Rev; 2009 Feb; 13(1):5-8. PubMed ID: 19059795
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.